enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Leflunomide - Wikipedia

    en.wikipedia.org/wiki/Leflunomide

    Leflunomide, sold under the brand name Arava among others, is an immunosuppressive disease-modifying antirheumatic drug , [8] used in active moderate-to-severe rheumatoid arthritis and psoriatic arthritis. It is a pyrimidine synthesis inhibitor that works by inhibiting dihydroorotate dehydrogenase. [9] Bottle of Leflunomide (Arava) and tablet

  3. Teriflunomide - Wikipedia

    en.wikipedia.org/wiki/Teriflunomide

    The branded drug teriflunomide is the main active in vivo metabolite of the generically available leflunomide. Upon administration of leflunomide, 70% of the drug administered converts into teriflunomide. The only difference between the molecules is the opening of the isoxazole ring.

  4. 8 Autoimmune Diseases That Cause Hair Loss - AOL

    www.aol.com/8-autoimmune-diseases-cause-hair...

    There aren’t any FDA-approved treatments for hair loss caused by autoimmune diseases. The best course of action is to work with your healthcare provider to manage the symptoms of your autoimmune ...

  5. 19 drug approvals in 2024 that had 'big clinical impact ... - AOL

    www.aol.com/19-drug-approvals-2024-had-093022917...

    GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of conditions. These medications are “slated to make a big clinical impact."

  6. Cereblon E3 ligase modulator - Wikipedia

    en.wikipedia.org/wiki/Cereblon_E3_ligase_modulator

    The thalidomide molecule is a synthetic derivative of glutamic acid and consists of a glutarimide ring and a phthaloyl ring (Figure 5). [15] [16] Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione and it has one chiral center [15] After thalidomide's selective inhibition of TNF-α had been reported, a renewed effort was put in thalidomide's clinical development.

  7. Genzyme's Once-daily, Oral AUBAGIO® (teriflunomide) Approved ...

    www.aol.com/2013/04/08/genzymes-once-daily-oral...

    Need help? Call us! 800-290-4726 Login / Join. Mail

  8. Abatacept - Wikipedia

    en.wikipedia.org/wiki/Abatacept

    Some people have had anaphylactic reactions to the drug. Abatacept may cause otherwise slow-growing cancers to proliferate and spread, due to suppression of the immune system. [5] Very common adverse effects (occurring in more than 10% of people) include upper respiratory tract infections.

  9. European Commission Approves Genzyme's Once-Daily, Oral ... - AOL

    www.aol.com/news/2013-08-30-european-commission...

    European Commission Approves Genzyme's Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide) CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE ...